These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 11174572)
1. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases. Epstein JB; Gorsky M; Epstein MS; Nantel S Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jan; 91(1):56-61. PubMed ID: 11174572 [TBL] [Abstract][Full Text] [Related]
2. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease. Epstein JB; Nantel S; Sheoltch SM Bone Marrow Transplant; 2000 Mar; 25(6):683-7. PubMed ID: 10734307 [TBL] [Abstract][Full Text] [Related]
3. The effect of budesonide mouthwash on oral chronic graft versus host disease. Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390 [TBL] [Abstract][Full Text] [Related]
4. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment. Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488 [TBL] [Abstract][Full Text] [Related]
5. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease. Epstein JB; Reece DE Bone Marrow Transplant; 1994 Jan; 13(1):81-6. PubMed ID: 8019458 [TBL] [Abstract][Full Text] [Related]
6. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836 [TBL] [Abstract][Full Text] [Related]
7. Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. Picardi A; Lanti A; Cudillo L; Cerretti R; Dentamaro T; De Angelis G; Ferraro A; Di Veroli A; Adorno G; Arcese W; Transfusion; 2010 Feb; 50(2):501-6. PubMed ID: 19821947 [TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
10. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877 [TBL] [Abstract][Full Text] [Related]
12. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease. Lee JH; Jung JY; Bang D J Eur Acad Dermatol Venereol; 2008 May; 22(5):590-5. PubMed ID: 18093111 [TBL] [Abstract][Full Text] [Related]
14. Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports. Utsman RA; Epstein JB; Elad S Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):e11-7. PubMed ID: 18585605 [TBL] [Abstract][Full Text] [Related]
15. A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation. Elad S; Ackerstein A; Bitan M; Shapira MY; Resnick I; Gesundheit B; Cohen Y; Diss O; Barak D; Dray L; Or R Bone Marrow Transplant; 2006 Apr; 37(8):757-62. PubMed ID: 16518424 [TBL] [Abstract][Full Text] [Related]
16. Budesonide: a novel treatment for oral chronic graft versus host disease. Elad S; Or R; Garfunkel AA; Shapira MY Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101 [TBL] [Abstract][Full Text] [Related]
17. Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD. Mawardi H; Stevenson K; Gokani B; Soiffer R; Treister N Bone Marrow Transplant; 2010 Jun; 45(6):1062-7. PubMed ID: 19881552 [TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature. Demarosi F; Soligo D; Lodi G; Moneghini L; Sardella A; Carrassi A Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918 [TBL] [Abstract][Full Text] [Related]
19. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127 [TBL] [Abstract][Full Text] [Related]
20. Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy. Epstein JB; Epstein JD; Epstein MS; Oien H; Truelove EL Spec Care Dentist; 2008; 28(2):73-7. PubMed ID: 18402621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]